IPSC
IPSC
US15673T1007
Century Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 109.164.000 6.589.000
1556.8%
Cost of Revenue -- --
--
Gross Profit -- --
--
119.670.000 140.399.000
14.8%
Operating Income -10.506.000 -133.810.000
92.1%
Pretax Income -9.648.000 -124.776.000
92.3%
Net Income Common Stockholders -9.580.000 -126.566.000
92.4%
-- --
--
-- --
--
ende